Abstract:While blood gene signatures have shown promise in tuberculosis (TB) diagnosis and treatment monitoring, most signatures derived from a single cohort may be insufficient to capture TB heterogeneity in populations and individuals. Here we report a new generalized approach combining a network-based meta-analysis with machine-learning modeling to leverage the power of heterogeneity among studies. The transcriptome datasets from 57 studies (37 TB and 20 viral infections) across demographics and TB disease states were used for gene signature discovery and model training and validation. The network-based meta-analysis identified a common 45-gene signature specific to active TB disease across studies. Two optimized random forest regression models, using the full or partial 45-gene signature, were then established to model the continuum from Mycobacterium tuberculosis infection to disease and treatment response. In model validation, using pooled multi-cohort datasets to mimic the real-world setting, the model provides robust predictive performance for incipient to active TB risk over a 2.5-year period with an AUROC of 0.85, 74.2% sensitivity, and 78.3% specificity, which approximates the minimum criteria (>75% sensitivity and >75% specificity) within the WHO target product profile for prediction of progression to TB. Moreover, the model strongly discriminates active TB from viral infection (AUROC 0.93, 95% CI 0.91–0.94). For treatment monitoring, the TB scores generated by the model statistically correlate with treatment responses over time and were predictive, even before treatment initiation, of standard treatment clinical outcomes. We demonstrate an end-to-end gene signature model development scheme that considers heterogeneity for TB risk estimation and treatment monitoring. Developing new diagnostic tools is one of the key areas to accelerate progress towards TB eradication. Having an accurate and rapid molecular test for TB detection in early stage has been highlighted in the recent updates of WHO guidelines and that facilitates faster treatment and reduces the risk of disease transmission. Blood gene signatures have shown promise in TB diagnosis, however, early detection and robust diagnosis against diverse populations are still the challenges to be overcome. Here we present a new computational approach leveraging the power of diverse clinical cohorts that not only defines a common gene signature specific to active TB disease but establishes a generalized predictive model. Importantly, we demonstrate robust performance of the model in both short-term and long-term TB risk estimation that provides a complementary approach to the current models, most of which offer good performance in active TB diagnosis and/or short-term TB risk estimation. In addition, we also demonstrate the utility of the model to monitor treatment responses along with Mycobacterium tuberculosis elimination, which provides additional information for evaluation before the end of treatment.

bvnGPS: a generalizable diagnostic model for acute bacterial and viral infection using integrative host transcriptomics and pretrained neural networks

Deep Learning Model to Discriminate Diverse Infection Types Based on Pairwise Analysis of Host Gene Expression

Clinical Characteristics Analysis and Construction of a Predictive Diagnostic Model of Community-Acquired Pneumonia in Adults Requiring Hospitalization in Fujian Provincial Hospital

Clinical characteristics analysis and predictive diagnostic model building of community-acquired pneumonia in adults requiring hospitalisation in Fujian Provincial Hospital

A prediction model based on machine learning for diagnosing the early COVID-19 patients

A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants

A machine learning classifier using 33 host immune response mRNAs accurately distinguishes viral and non-viral acute respiratory illnesses in nasal swab samples

Integrating a host transcriptomic biomarker with a large language model for diagnosis of lower respiratory tract infection

Integrated Analysis of Human Influenza A (H1N1) Virus Infectionrelated Genes to Construct a Suitable Diagnostic Model

Prediction of virus-host infectious association by supervised learning methods

Predicting the hosts of prokaryotic viruses using GCN-based semi-supervised learning

Real-time Utilization of Metagenomic Sequencing in the Diagnosis and Treatment Monitoring of an Invasive Adenovirus B55 Infection and Subsequent Herpes Simplex Virus Encephalitis in an Immunocompetent Young Adult.

Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis

Prokaryotic virus host predictor: a Gaussian model for host prediction of prokaryotic viruses in metagenomics

Predicting hosts and cross-species transmission of Streptococcus agalactiae by interpretable machine learning

The diagnostic value of nasal microbiota and clinical parameters in a multi-parametric prediction model to differentiate bacterial versus viral infections in lower respiratory tract infections

The relationships among host transcriptional responses reveal distinct signatures underlying viral infection-disease associations

A microbial knowledge graph-based deep learning model for predicting candidate microbes for target hosts

Virus-host interactions predictor (VHIP): Machine learning approach to resolve microbial virus-host interaction networks

Analysis of gene expression dynamics and differential expression in viral infections using generalized linear models and quasi-likelihood methods

Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment